| Title | Author(s) | Year | View Count |
 | Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine | Sandhya, V; Schlesinger, SJ; Chen, Z; Hurley, A; Lombardo, A; Than, S; Adesanya, P; Bunce, C; Boaz, M; Boyle, R; Sayeed, E; Clark, L; Dugin, D; Boente-Carrera, M; Schmidt, C; Fang, Q; LeiBa,; Huang, Y; Zaharatos, GJ; Gardiner, DF; Caskey, M; Seamons, L; Ho, M; Dally, L; Smith, C; Cox, J; Gill, D; Gilmour, J; Keefer, MC; Fast, P; Ho, DD | 2010 | 189 |
| Phase I safety and immunogenicity evaluation of ADVAX, a Multigenic, DNA-based Clade C/B' HIV-1 candidate vaccine | Vasan, S; Schlesinger, SJ; Huang, Y; Hurley, A; Lombardo, A; Chen, Z; Than, S; Adesanya, P; Bunce, C; Boaz, M; Boyle, R; Sayeed, E; Clark, L; Dugin, D; Schmidt, C; Song, Y; Seamons, L; Dally, L; Ho, M; Smith, C; Markowitz, M; Cox, J; Gill, DK; Gilmour, J; Keefer, MC; Fast, P; Ho, DD | 2010 | 184 |
 | Design, Construction, and Characterization of a Dual-Promoter Multigenic DNA Vaccine Directed against an HIV-1 Subtype C/B’ Recombinant | Huang, Y; Chen, Z; Zhang, W; Song, Y; Zhao, X; Gardiner, DF; Ho, DD | 2008 | 114 |
 | Design, construction, and characterization of a multigenic modified vaccinia ankara candidate vaccine against human immunodeficiency virus type 1 subtype C/B′ | Chen, Z; Huang, Y; Zhao, X; Ba, L; Zhang, W; Ho, DD | 2008 | 45 |
| Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B′ recombinant | Huang, Y; Chen, Z; Zhang, W; Gurner, D; Song, Y; Gardiner, DF; Ho, DD | 2008 | 60 |
| The changing face of HIV in China | Lu, L; Jia, M; Ma, Y; Yang, L; Chen, Z; Ho, DD; Jiang, Y; Zhang, L | 2008 | 56 |
| Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, α-galactosylceramide | Huang, Y; Chen, A; Li, X; Chen, Z; Zhang, W; Song, Y; Gurner, D; Gardiner, D; Basu, S; Ho, DD; Tsuji, M | 2008 | 64 |
| Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus | Ba, L; Yi, CE; Zhang, L; Ho, DD; Chen, Z | 2007 | 179 |
| Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus | Liu, L; Fang, Q; Deng, F; Wang, H; Yi, CE; Ba, L; Yu, W; Lin, RD; Li, T; Hu, Z; Ho, DD; Zhang, L; Chen, Z | 2007 | 46 |
| Multiple-site DNA vaccination enhances immune responses in mice | Gardiner, DF; Huang, Y; Basu, S; Leung, L; Song, Y; Chen, Z; Ho, DD | 2006 | 63 |
| Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan Province of China | Zhang, Y; Lu, L; Ba, L; Liu, L; Yang, L; Jia, M; Wang, H; Fang, Q; Shi, Y; Yan, W; Chang, G; Zhang, L; Ho, DD; Chen, Z | 2006 | 62 |
| SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus | Woo, PCY; Lau, SKP; Tsoi, HW; Chen, ZW; Wong, BHL; Zhang, L; Chan, JKH; Wong, LP; He, W; Ma, C; Chan, KH; Ho, DD; Yuen, KY | 2005 | 144 |
| Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region | Chen, Z; Zhang, L; Qin, C; Ba, L; Yi, CE; Zhang, F; Wei, Q; He, T; Yu, W; Yu, J; Gao, H; Tu, X; Gettie, A; Farzan, M; Yuen, KY; Ho, DD | 2005 | 265 |
| Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain | Yi, CE; Ba, L; Zhang, L; Ho, DD; Chen, Z | 2005 | 44 |
| Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in China | Zhang, L; Chen, Z; Cao, Y; Yu, J; Li, G; Yu, W; Yin, N; Mei, S; Li, L; Balfe, P; He, T; Ba, L; Zhang, F; Lin, HH; Yuen, MF; Lai, CL; Ho, DD | 2004 | 384 |
| Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics | Kao, RY; Tsui, WHW; Lee, TSW; Tanner, JA; Watt, RM; Huang, JD; Hu, L; Chen, G; Chen, Z; Zhang, L; He, T; Chan, KH; Tse, H; To, APC; Ng, LWY; Wong, BCW; Tsoi, HW; Yang, D; Ho, DD; Yuen, KY | 2004 | 212 |
| CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic simian/human immunodeficiency virus (SHIV) | Chen, Z; Zhao, X; Huang, Y; Gettie, A; Ba, L; Blanchard, J; Ho, DD | 2002 | 54 |
| Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina) | Chen, Z; Huang, Y; Zhao, X; Skulsky, E; Lin, D; Ip, J; Gettie, A; Ho, DD | 2000 | 55 |
| The Morberg pickup test: Results of testing with a standard protocol | Ng, CL; Ho, DD; Chow, SP | 1999 | 112 |
| The Moberg pickup test: Results of testing with a standard protocol | Ng, CL; Ho, DD; Chow, SP | 1999 | 59 |
|
